Transmucosal Administration System for a Pharmaceutical Drug

The invention generally relates to transmucosal administration systems for administering quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The present invention more specifically relates to methods of treatment for Duchenne Muscular Dystrophy that includes administ...

Full description

Saved in:
Bibliographic Details
Main Authors KRUMME, Markus, HAUSMANN, Rudolf, JENSEN, Keith, DUBACH-POWELL, Judith
Format Patent
LanguageEnglish
Published 21.11.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention generally relates to transmucosal administration systems for administering quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The present invention more specifically relates to methods of treatment for Duchenne Muscular Dystrophy that includes administering to a patient a dose in the form of one or more transmucosal administration systems.
Bibliography:Application Number: US201916531707